• Identify risk areas in chargemaster (CDM) pricing that are often overlooked.
• Describe ways to rationalize and defend pricing.
• Effectuate processes to stay current with price transparency regulations.
Dr. Mathias Zadrazil is Chief Compliance Officer EMEA at Zimmer Biomet in Zug since September 2023. Prior to that, he worked as General Counsel Legal & Compliance International at the US medtech company Cardinal Health. Professional career: Vice President Pharma Law at Novo Nordisk in Copenhagen, before that General Counsel L&C Europe at Novo Nordisk in Zurich. His in-house career started as Legal Counsel in Novartis Pharma AG in Basel; Before that, he was a lawyer at Vischer law firm. Mathias studied at the University of Freiburg (DE), received his doctorate from the University of Lausanne, obtained an LL.M. in Montreal and is admitted to the bar in Switzerland and Germany.
Kersten Schmahl is Senior Director Ethics & Compliance Intercontinental at CSL, a global listed biotech company. He previously held various international Ethics & Compliance leadership positions with both listed and privately-held pharmaceutical, biotech and medical technology companies being based in Germany, Switzerland, and Sweden.
Kersten graduated from the University of St. Gallen, Switzerland, and Leuphana University in Luneburg, Germany. At the latter University, he has teaching assignments for Compliance & Investigations in Corporate Practice since 2009. Kersten is also a standing co-author for the chapter “Compliance in the Pharmaceutical & Medical Technology Industry” in the Handbook of Corporate Legal Management – Manual for Corporate Compliance in Germany.
